{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:46:33Z","timestamp":1777725993119,"version":"3.51.4"},"reference-count":9,"publisher":"SAGE Publications","issue":"1_suppl","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[2016,9]]},"abstract":"\n Objective<\/jats:title>\n Retrospective study to evaluate the incidence of infectious adverse events in patients with psoriasis treated with etanercept.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Patients with psoriasis or psoriatic arthritis who were treated with etanercept (50\u2009mg, administered weekly via subcutaneous injection) for \u226548 weeks were retrospectively enrolled. Patients were screened for occult infections before treatment commenced, and then every 12 months thereafter. Minor (not requiring hospitalization and\/or discontinuation of treatment) and major (requiring hospitalization and\/or discontinuation of treatment) infectious events were recorded.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The study included 50 patients. Minor infectious events included self-limiting upper respiratory tract infections (six patients), lower urinary tract infections (one patient) and recurrent herpes simplex labialis (two patients). Major infections occurred in only two cases.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n These data support the good safety profile of etanercept in patients with psoriasis or psoriatic arthritis.<\/jats:p>\n <\/jats:sec>","DOI":"10.1177\/0300060515593252","type":"journal-article","created":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T21:17:38Z","timestamp":1475356658000},"page":"58-60","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term safety of etanercept in psoriasis: Retrospective study focused on infections"],"prefix":"10.1177","volume":"44","author":[{"given":"Diego","family":"Orsini","sequence":"first","affiliation":[{"name":"Dermatology Unit, Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), University of Rome \u201cLa Sapienza\u201d, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Narcisi","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), University of Rome \u201cLa Sapienza\u201d, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Arcese","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), University of Rome \u201cLa Sapienza\u201d, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Costanzo","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), University of Rome \u201cLa Sapienza\u201d, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,9,28]]},"reference":[{"key":"bibr1-0300060515593252","doi-asserted-by":"publisher","DOI":"10.1046\/j.1087-0024.2003.09102.x"},{"key":"bibr2-0300060515593252","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6621"},{"key":"bibr3-0300060515593252","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804595"},{"key":"bibr4-0300060515593252","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-7310(14)70014-6"},{"key":"bibr5-0300060515593252","doi-asserted-by":"crossref","unstructured":"Nast A, Jacobs A, Rosumeck S, et\u00a0al. Efficacy and Safety of Systemic Long-term Treatments for Moderate-to-Severe Psoriasis \u2013 A Systematic Review and Meta-Analysis.\n J Invest Dermatol\n 2015 Jun 5. doi: 10.1038\/jid.2015.206.","DOI":"10.1038\/jid.2015.206"},{"key":"bibr6-0300060515593252","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.8.4.491"},{"key":"bibr7-0300060515593252","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0336"},{"key":"bibr8-0300060515593252","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i43.16014"},{"key":"bibr9-0300060515593252","first-page":"e41","volume":"12","author":"Tan X","year":"2013","journal-title":"J Drugs Dermatol"}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0300060515593252","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0300060515593252","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0300060515593252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:44:30Z","timestamp":1777459470000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0300060515593252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":9,"journal-issue":{"issue":"1_suppl","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1177\/0300060515593252"],"URL":"https:\/\/doi.org\/10.1177\/0300060515593252","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}